FDA Clears First AI-Powered Device to Help Doctors Better Detect Skin Cancer
-
FDA granted clearance for DermaSensor, the first AI-powered handheld device to help doctors detect 3 common skin cancers (basal cell, squamous cell, melanoma)
-
Device uses spectroscopy and AI to analyze skin lesions and provide physicians with diagnostic information
-
Clinical trials showed DermaSensor improved doctors' sensitivity to detecting malignancy from 83% to 95.5%
-
Helped lower missed skin cancer diagnoses from 18% to 9% in study with 108 primary care physicians
-
Expected to accelerate access to treatment by improving skin cancer identification and referrals in primary care